Research location

Princeton

New Jersey, United States

Published trials207

Site observations209

Linked trials published207

Page1 / 5

Research activity in Princeton

New Jersey, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 207 trials and 209 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Princeton

207 linked trials · page 1 of 5

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid TumorsNCT07278479 · 2026-05-18 · 1 site observation

Phase 1 Study of CLR 125 in Triple Negative Breast CancerNCT07311993 · 2025-12-05 · 1 site observation

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)NCT06937229 · 2025-12-02 · 1 site observation

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)NCT07011732 · 2025-07-10 · 1 site observation

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)NCT07076407 · 2025-07-08 · 1 site observation

GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort StudyNCT07588984 · 2026-04-30 · 1 site observation

NOT_YET_RECRUITING

Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)NCT07214961 · 2025-11-03 · 1 site observation

ACTIVE_NOT_RECRUITING

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast CancerNCT07121244 · 2025-10-01 · 1 site observation

Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)NCT06605105 · 2025-07-18 · 1 site observation

ENROLLING_BY_INVITATION

An Open-Label Study of Azetukalner in Major Depressive DisorderNCT06922110 · 2025-03-18 · 1 site observation

ENROLLING_BY_INVITATION

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"NCT06564818 · 2024-12-17 · 1 site observation

ACTIVE_NOT_RECRUITING

To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.NCT06429722 · 2024-05-13 · 1 site observation

Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate CancerNCT06235151 · 2024-04-01 · 1 site observation

ACTIVE_NOT_RECRUITING

PD, PK, and Safety of ALTO-203 in Patients With MDDNCT06391593 · 2024-03-25 · 1 site observation

Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's DiseaseNCT06268886 · 2024-03-20 · 1 site observation

ACTIVE_NOT_RECRUITING

Psilocybin for Major Depressive Disorder (MDD)NCT06308653 · 2024-03-13 · 1 site observation

ACTIVE_NOT_RECRUITING

Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNCT06058013 · 2023-12-20 · 1 site observation

Study to Assess the Safety and Effectiveness of NMRA-335140-501NCT06029439 · 2023-11-10 · 1 site observation

Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsNCT05799274 · 2023-11-09 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study to Evaluate Safety of Exposure to Wegovy During PregnancyNCT05872022 · 2023-07-05 · 1 site observation

ENROLLING_BY_INVITATION

Study of AV-1959D, an Amyloid Beta VaccineNCT05642429 · 2023-02-27 · 1 site observation

ACTIVE_NOT_RECRUITING

A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's DiseaseNCT05644977 · 2022-12-02 · 1 site observation

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)NCT05602727 · 2022-12-02 · 1 site observation

Open-label Extension for Phase 3 Clinical Trials of SimufilamNCT05575076 · 2022-11-07 · 1 site observation

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)NCT05189210 · 2022-10-05 · 1 site observation

A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)NCT05466422 · 2022-09-20 · 1 site observation

A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/SertralineNCT05189977 · 2022-09-07 · 1 site observation

Tracking Treatment Pathways in Adult Patients With Hyperkalemia.NCT05408039 · 2022-07-14 · 1 site observation

Elpipodect (MK-8189) Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017)NCT05227118 · 2022-07-01 · 1 site observation

RADIANCE Continued Access ProtocolNCT05017935 · 2022-05-04 · 1 site observation

ACTIVE_NOT_RECRUITING

Screening for High Frequency Malignant DiseaseNCT05117840 · 2022-01-13 · 1 site observation

ACTIVE_NOT_RECRUITING

A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.NCT05169710 · 2021-12-21 · 1 site observation

A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 DiabetesNCT05144984 · 2021-11-29 · 1 site observation

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's DiseaseNCT05026177 · 2021-11-18 · 1 site observation

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 InflammationNCT04773678 · 2021-05-11 · 1 site observation

A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseNCT04619420 · 2021-01-06 · 1 site observation

A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive DisorderNCT04476030 · 2020-11-09 · 1 site observation

A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's DiseaseNCT04520412 · 2020-10-27 · 1 site observation

Transitional Care Model Evaluation 2020NCT04212962 · 2020-07-07 · 1 site observation

ACTIVE_NOT_RECRUITING

To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD DementiaNCT04311515 · 2020-06-30 · 1 site observation

A Study to Evaluate the Safety of Exposure to Wegovy During PregnancyNCT05503927 · 2020-02-01 · 1 site observation

ENROLLING_BY_INVITATION

Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's DiseaseNCT04149860 · 2019-09-27 · 1 site observation

A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) RegisterNCT05413044 · 2019-07-01 · 1 site observation

Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's DiseaseNCT03867253 · 2019-05-16 · 1 site observation

GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's DiseaseNCT03823404 · 2019-03-28 · 1 site observation

An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)NCT03712787 · 2019-03-22 · 1 site observation

A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)NCT03864614 · 2019-02-27 · 1 site observation

Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's DiseaseNCT03486938 · 2018-12-13 · 1 site observation

Study of BHV-4157 in Alzheimer's DiseaseNCT03605667 · 2018-07-31 · 1 site observation

A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of DepressionNCT03559192 · 2018-07-16 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.